DOYLESTOWN, Pa., July 30 /PRNewswire-FirstCall/ -- The Quigley Corporation, (NASDAQ:QGLY), http://www.quigleyco.com/ today announced it will issue its second quarter results before market open on Wednesday, August 5, 2009. Ted Karkus, Chairman and CEO, will provide a Company overview including a review of recent activities and second quarter results on a conference call which will be web cast on The Quigley Corporation's web site, (http://www.quigleyco.com/), at 10:00 AM (ET) that morning. A replay of the conference call will be available for 30 days on the Company web site. About The Quigley Corporation The Quigley Corporation (NASDAQ:QGLY) (http://www.quigleyco.com/) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufacturer of the COLD-EEZE family of lozenges, gums and sugar free tablets clinically proven to significantly reduce the severity and duration of the common cold. COLD-EEZE customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. The Quigley Corporation has several wholly owned subsidiaries including Quigley Manufacturing Inc., which consists of an FDA approved facility to manufacture COLD-EEZE lozenges and fulfill other contract manufacturing opportunities, and Quigley Pharma Inc., (http://www.quigleypharma.com/), which conducts research in order to develop and commercialize a pipeline of patented botanical and naturally derived potential prescription drugs. Forward-Looking Statements Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve known and unknown risk, uncertainties and other factors that may cause the Company's actual performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statement. Factors that impact such forward-looking statements include, among others, changes in worldwide general economic conditions, changes in interest rates, government regulations, and worldwide competition. CONTACT: Ted Karkus Media Investor Relations Chairman of the Board, CEO Karen Pineman Carl Hymans The Quigley Corporation G.S. Schwartz & Co. G.S. Schwartz & Co. (215) 345-0919 212.725.4500 212.725.4500 DATASOURCE: The Quigley Corporation CONTACT: Ted Karkus, Chairman of the Board, CEO, The Quigley Corporation, +1-215-345-0919; Media: Karen Pineman, G.S. Schwartz & Co., , or Investor Relations: Carl Hymans, , both of G.S. Schwartz & Co., +1-212-725-4500 Web Site: http://www.quigleyco.com/

Copyright

Grafico Azioni The Quigley (MM) (NASDAQ:QGLY)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di The Quigley (MM)
Grafico Azioni The Quigley (MM) (NASDAQ:QGLY)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di The Quigley (MM)